Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk.
Saved in:
| Title: | Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk. |
|---|---|
| Authors: | Prizment AE; Minneapolis, MN, USA., Staley C; Minneapolis, MN, USA., Onyeaghala GC; Minneapolis, MN, USA., Vivek S; Minneapolis, MN, USA., Thyagarajan B; Minneapolis, MN, USA., Straka RJ; Minneapolis, MN, USA., Demmer RT; Minneapolis, MN, USA.; New York, NY, USA., Knights D; Minneapolis, MN, USA., Meyer KA; Chapel Hill, NC, USA., Shaukat A; Minneapolis, MN, USA., Sadowsky MJ; Minneapolis, MN, USA., Church TR; Minneapolis, MN, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Sep; Vol. 52 (6), pp. 976-987. Date of Electronic Publication: 2020 Aug 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.16013 |
